PATENT CLAIM ANALYSIS

Application Number: 16073934
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-05
Patent Classification: ["514", "403000"]

Abstract:
Disclosed are compounds of formula I, and pharmaceutically acceptable salts thereof. The compounds are inhibitors of the complement system. Also provided are pharmaceutical compositions comprising a compound of formula I, and methods involving use of the compounds and compositions in the treatment and prevention of diseases and conditions characterized by aberrant complement system activity.

Claim (Index 23):
The compound of  claim 18 , wherein:\n Z 4  represents CR 8 ; Z 5  represents CR 5 ; Z 6  represents CR 6 ; and Z 7  represents CR 9 .

Metadata:
- Claim Count in Document: 29.0
- Percentile: 95.0
- Lexical Diversity: 1.59459
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15764071', '15247429', '14631828', '15905524', '15700550']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7908494355104148
- 35 USC 102 Novelty (BERT): 0.5551837417167915
- Combined Prediction Score: 0.7672828661310525
- Mean Citation Score: 398.325606
- Max Citation Score: 429.99738
- Similarity Product: 276.81717470155843

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test